Back to Screener

Healthcare

North American Cannabis Holdings, Inc.(USMJ)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+900.00%

Window

Jun 20, 2025 โ†’ Jun 12, 2026

Market Cap
โ€”
Revenue Growth
-6.6%
EPS Growth
0.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 20, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

North American Cannabis Holdings, Inc. (USMJ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 20, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of -6.6%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue -6.6%, EPS 0.0%, free cash flow +169.3% with operating margin -5.9% and ROIC 3.8%. Valuation sits in the middle of the pack at price/sales 7.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines USMJ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-6.6% vs +7.6% peer median

Operating Margin

Below sector median

-5.9% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2019 was reported on Oct 15, 2019, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -6.6% and EPS is at 0.0%, with operating margin around -5.9%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2019
Oct 15, 2019
โ€”+0.0%+0.0%+0.0%
2011
Mar 31, 2011
โ€”+0.0%+0.0%+0.0%
2010
Dec 31, 2010
โ€”+0.0%+0.0%+0.0%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

USMJ

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

USMJ Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for USMJ and SPY.

Calendar-year return history is still loading or unavailable.
North American Cannabis Holdings, Inc. logo

Company Overview

North American Cannabis Holdings, Inc.

Other OTC

North American Cannabis Holdings, Inc., through its subsidiaries, operates in the legal cannabis market in the United States. It conducts various pilots in the legal cannabis sector in order to explore various high growth potential business opportunities. The company also operates a destination beverage company that enables consumers to interface with staff to learn about the specific benefits of cannabis, and select healthy and refreshing cannabis infused beverages, which include custom blended hemp infused coffee, cold pressed juices, and smoothies. In addition, it offers raw hemp seeds and other hemp infused foods. North American Cannabis Holdings, Inc. was formerly known as Algae International Group, Inc. and changed its name to North American Cannabis Holdings, Inc. in June 2015. The company is based in Farmers Branch, Texas.

Leadership
Steven Rash
IPO Date
Nov 9, 1998
Employees
2
Street Address
14065 Proton Road
Mailing
Dallas, TX, 75244
Region
Dallas, TX, US
Reporting Currency
USD
Investor Line
214-937-9097
Last Updated
May 5, 2026
CIK: 0001096915ISIN: US65676T1025CUSIP: 65676T102
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
7.2
Price/Book
โ€”

Growth

Revenue
-6.6%
EPS
0.0%
Free Cash Flow
+169.3%

Profitability

Gross Margin
68.4%
Operating Margin
-5.9%
Net Margin
-355.4%
ROE
40.3%
ROIC
3.8%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.22

Earnings Reports

๐Ÿ“… Last reportedOct 15, 2019
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Oct 15, 19
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 11
-361.60
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 10
76.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 10
-5445.68
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 10
-3416.60
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 10
-301.85
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 09
-209.57
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 09
-276.22
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 09
-28.40
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 09
-29.77
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 08
-27.95
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 08
-285.96
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 08
-70.53
Est โ€”
โ€”
4.6B
Est โ€”
โ€”
โ€”
Sep 30, 07
-30.52
Est โ€”
โ€”
17.7B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.